ASHPOfficial

The ongoing opioid epidemic in the United States (US) is entering a new phase with the Covid-19 pandemic. Overdose deaths are increasing in the US and opioid use disorder (OUD) is one of the main contributors to this issue. Naloxone is a life saving medication for opioid reversal but requires timely administration. Unfortunately, due to cost and other limitations such as prescription status, naloxone is not always available when it is needed most. Emergency Departments (ED) and hospitals can play a vital role in establishing naloxone distribution services and put this life-saving medications directly into the hands of patients that may need it. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s Executive Forum on Cold Chain Management convened virtually on April 19 to review the current state of pharmaceutical cold chain management in health systems. The event was the first in a series of executive forums on cold chain management and part of the ASHP Innovation Center’s efforts to influence innovation and digital transformation to advance the safe and effective use of medicines. This podcast explores key takeaways from the executive forum event and the importance of the pharmaceutical cold chain to public health needs. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

We will discuss the current FDA-approved first-line NCCN Category 1 treatment options for relapsed or stage IV clear cell RCC, specifically evaluating the various immunotherapy (IO) combination therapies, their clinical application, and considerations for choosing between available combinations. We will also review the side effect/toxicity profile and management strategies for each therapy.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The MAT Act has been introduced in the 117th congress and would eliminate the burdensome x waiver which requires that a health care practitioner apply for a separate waiver through the DEA to dispense certain narcotic drugs (e.g., buprenorphine) for substance use disorder treatment. The MAT Act would increase treatment access for patients to medication assisted treatment and make it easier for clinicians to provide substance use disorder treatment to their patients.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the 2021 Midyear Clinical Meeting, our content matter experts identify the challenges and share the solutions for transgender people navigating the healthcare system and discuss the clinical concerns and controversies in comprehensive medication management for transgender people.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode provides an overview of how healthcare providers may initiate transitions of care services. Speakers share both successes and challenges experienced when implementing their own transitions of care services as well as how they were able to overcome barriers. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recently updated the pneumococcal vaccination recommendations and guidelines to include two newly approved vaccines. The updated guidelines provide a more streamlined method for patients across age and risk groups. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses strategies to improve engagement, emotional components of retention and job satisfaction, and methods to recognize the valuable role technicians provide in patient care. With the heightened national issue around healthcare burnout and how this impacts professional satisfaction and retention for pharmacy technicians this discussion provides insights how organizations have made improvements to support their pharmacy technicians.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, Dr. Tristan Maiers, Dr. Alicia Mattson, and Dr. Kristen Baron discuss their respective articles entitled, “Impact of a pharmacist-led telehealth oral chemotherapy clinic”, “Description of telepharmacy services by emergency medicine pharmacists”, and “Evaluation of a remote hybrid staffing model for ambulatory clinical pharmacists in a pediatric health system during the COVID-19 pandemic”, which were published in the AJHP theme issue on Telehealth, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast, we will be talking with Tina Claypool. We will discuss her involvement with Kentucky Society of Health-System Pharmacists (KSHP) Women in Pharmacy Committee and the integration of students with state affiliates. This relationship is beneficial by encouraging professional growth, mentorship, and furthering the provision of pharmacy care. The audience will gain insight on inclusion and how to involve themselves with state affiliates. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.